Erste Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30,700
Closed -$147K 681
2023
Q2
$147K Hold
30,700
﹤0.01% 505
2023
Q1
$163K Hold
30,700
﹤0.01% 505
2022
Q4
$307K Hold
30,700
0.01% 457
2022
Q3
$686K Hold
30,700
0.02% 386
2022
Q2
$764K Buy
30,700
+10,000
+48% +$276K 0.02% 388
2022
Q1
$825K Buy
20,700
+9,500
+85% +$368K 0.02% 378
2021
Q4
$663K Sell
11,200
-6,000
-35% -$340K 0.01% 403
2021
Q3
$1.03M Hold
17,200
0.02% 337
2021
Q2
$1.53M Hold
17,200
0.03% 313
2021
Q1
$1.27M Sell
17,200
-5,500
-24% -$527K 0.03% 318
2020
Q4
$2.1M Buy
+22,700
New +$1.41M 0.06% 259

Other funds holding FATE